Focus: Baxter International is a $10.4B global medical devices and specialty pharmaceuticals company headquartered in Deerfield, IL, with 50,000+ employees serving critical care, renal, and nutritional therapy markets. The company operates as a diversified healthcare leader with strong scale in hospital and clinical settings.
Profile data last refreshed 1h ago · AI intelligence enriched 1w ago
Hot — 923 jobs added in 30d
Net +379 (923 new, 544 removed). Aggressive expansion phase.
Strong choice for device/manufacturing/IT careers seeking stability and scale; less appealing for drug hunters or those betting on pharma innovation pipelines.
Help build intelligence for Baxter International
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Baxter International's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Could NYSE Composite Trends Pressure Baxter International Shares? - Kalkine Media
Could NYSE Composite Trends Pressure Baxter International Shares? Kalkine Media
Baxter International Inc. stock (US0673431090): pharma supplier in focus after latest price swings - AD HOC NEWS
Baxter International Inc. stock (US0673431090): pharma supplier in focus after latest price swings AD HOC NEWS
Baxter International Inc. Stock (US0673431090): Q1 2026 Earnings Beat Expectations on Strong Sales G - AD HOC NEWS
Baxter International Inc. Stock (US0673431090): Q1 2026 Earnings Beat Expectations on Strong Sales G AD HOC NEWS
8-K Filing: HOLOGIC INC (HOLX) (CIK 0000859737) — EX-99.1
EX-99.1
8-K Filing: Inogen Inc (INGN) (CIK 0001294133) — EX-99.1
EX-99.1
Baxter International stock faces pressure from ifosfamide shortage and reduced production capacity a - AD HOC NEWS
Baxter International stock faces pressure from ifosfamide shortage and reduced production capacity a AD HOC NEWS
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo